For Patients Needing Oral Anticoagulation for Atrial Fibrillation and Dual Antiplatelet Therapy after Percutaneous Coronary Intervention, Is Double Therapy Preferred over Triple Therapy?

Podobne knjige/članki

• Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent
  od: De Vecchis, Renato, et al.
  Izdano: (2016)
• Management of Anticoagulation in Patients with Atrial Fibrillation Undergoing PCI: Double or Triple Therapy?
  od: Peterson, Benjamin E., et al.
  Izdano: (2018)
• Dual antiplatelet therapy with concomitant anticoagulation: current perspectives on triple therapy
  od: Haris Patail, et al.
  Izdano: (2023-02-01)
• Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
  od: Limbruno, Ugo, et al.
  Izdano: (2020)
• Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants
  od: Goette, Andreas, et al.
  Izdano: (2020)